Home > Boards > US Listed > Biotechs > Invitae Corp. (NVTA)

It got pretty darn low there and hasn't

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
shub Member Profile
 
Followed By 12
Posts 1,387
Boards Moderated 0
Alias Born 04/12/11
160x600 placeholder
3 Healthcare Stocks Cathie Wood Is Bullish On! Finscreener.org - 9/22/2021 7:13:00 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 9/15/2021 4:17:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 9/14/2021 4:08:07 PM
Dante Labs Announces Expansion of its Finance Team with the Appointment of Andre Nel as Chief Financial Officer, Dalila Rahmani as Chief Accounting Officer, Laura D’Angelo as VP Investor Relations and Omar Elbakshish as Senior Director GlobeNewswire Inc. - 9/14/2021 7:30:00 AM
What Can Investors Learn from Invitae’s Newly Added Risk Factors? TipRanks - 9/10/2021 6:19:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/7/2021 8:02:09 AM
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research PR Newswire (US) - 9/7/2021 7:00:00 AM
Invitae to Present at the Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire (US) - 9/1/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2021 7:06:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2021 6:16:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2021 7:39:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2021 6:10:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2021 6:05:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/18/2021 6:05:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/9/2021 5:28:24 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2021 5:04:07 PM
Invitae to Present at the UBS Genomics 2.0 and MedTech Innovations Summit PR Newswire (US) - 8/9/2021 4:01:00 PM
Invitae shares rise on Q2 earnings beat, FY revenue forecast raise Seeking Alpha - 8/3/2021 4:20:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2021 4:10:08 PM
Invitae EPS beats by $0.06, beats on revenue Seeking Alpha - 8/3/2021 4:07:29 PM
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021 PR Newswire (US) - 8/3/2021 4:05:00 PM
Volpara Collaborates With Invitae Corporation, Leading Genetics Company PR Newswire (US) - 7/22/2021 8:00:00 AM
Pacific Bio to acquire Omniome, sees Q2 of $30.5M above consensus Seeking Alpha - 7/20/2021 8:07:45 AM
Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021 PR Newswire (US) - 7/20/2021 7:30:00 AM
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration GlobeNewswire Inc. - 7/20/2021 7:02:00 AM
shub   Monday, 05/21/18 03:14:23 PM
Re: madprophet post# 53
Post # of 104 
It got pretty darn low there and hasn't come up much.
Given the great growth rate...
It's awfully cheap now.
There's some risk , obviously,
but the upside potential is staggering.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences